Exploring the role of a glycosylated L-asparaginase expressed by a recombinant Pichia pastoris as an antileukemic biopharmaceutical (2021)
- Authors:
- Autor USP: KLEINGESINDS, EDUARDO KREBS - FCF
- Unidade: FCF
- Sigla do Departamento: FBT
- DOI: 10.11606/T.9.2021.tde-21122021-144906
- Subjects: LEUCEMIA; BIOPROCESSOS; PROTEÍNAS RECOMBINANTES
- Keywords: Bioprocess; Bioprocesso; Co-cultura; Co-culture; Leucemia; Leukemia; Microambiente tumoral; Proteínas recombinantes; Recombinant proteins; Tumor microenvironment
- Agências de fomento:
- Language: Inglês
- Abstract: According to the World Health Organization (WHO), in 2020, 474 519 new cases of leukemia were reported around the world, and 311 594 new deaths were reported. The importance of L-asparaginase (LASNase) as a biopharmaceutical to treat Acute Lymphoblastic Leukemia (ALL) is recognized worldwide. This work describes the bioprocessing of L-ASNase from Erwinia chrysanthemi expressed extracellularly by Pichia pastoris with a human-like glycosylation pattern. Firstly, it was optimized the upstream conditions in the orbital shaker flask. Then, it was scaled up using a 3L benchtop bioreactor at batch mode under 35 °C and 1.5% methanol as an inductor for L-ASNase production. The downstream processing was evaluated using crossflow ultrafiltration with different cut-offs (10-100 kDa) followed by cation exchange chromatography and size exclusion chromatography. It was possible to reach a final yield of 54.93% with a purification factor of 70.93 fold and the proteomics data confirmed the attainment of an extremely pure enzyme. At pH 8.0 and 50 °C, the enzyme showed its optimum activity. Kinetic parameters, ‘k IND.M’ and ‘V IND.MAX’, were found to be 76.4 µM and 0.065 µmol ‘min POT.-1’, respectively. The thermodynamic study showed that the enzyme irreversible deactivation is well described by first-order kinetics. Finally, using a high throughput fluorescentbased in vitro experimental platform, it was investigated the concomitant impact of this recombinant L-ASNase on enhanced green fluorescent protein (eGFP)-labeled tumor cell lines (SEMK2, HB119, REH, and MV411) when co-cultured with the mCherry-labelled bone marrow fibroblastic stroma cells HS5. The outcomes of this research suggest that the eGFP-Hb11-9 strain was the most sensitive strain when treated with the glycosylated L-ASNase, in contrast with the eGFP-REH that was the most resistant linage. It was also observed lower effectiveness of thedrug when tumor cells were co-cultured with stromal cells than when tumor cells were cultured on their own. Hence, this work paves the way for production, scale-up, and pre-clinical trials of this promising novel biopharmaceutical, which may help improve the remission rates and quality of life for many cancer patients around the world
- Imprenta:
- Data da defesa: 03.12.2021
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
KLEINGESINDS, Eduardo Krebs. Exploring the role of a glycosylated L-asparaginase expressed by a recombinant Pichia pastoris as an antileukemic biopharmaceutical. 2021. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2021. Disponível em: https://www.teses.usp.br/teses/disponiveis/9/9134/tde-21122021-144906/. Acesso em: 11 mar. 2026. -
APA
Kleingesinds, E. K. (2021). Exploring the role of a glycosylated L-asparaginase expressed by a recombinant Pichia pastoris as an antileukemic biopharmaceutical (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/9/9134/tde-21122021-144906/ -
NLM
Kleingesinds EK. Exploring the role of a glycosylated L-asparaginase expressed by a recombinant Pichia pastoris as an antileukemic biopharmaceutical [Internet]. 2021 ;[citado 2026 mar. 11 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9134/tde-21122021-144906/ -
Vancouver
Kleingesinds EK. Exploring the role of a glycosylated L-asparaginase expressed by a recombinant Pichia pastoris as an antileukemic biopharmaceutical [Internet]. 2021 ;[citado 2026 mar. 11 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9134/tde-21122021-144906/ - Avaliação da hidrólise enzimática do sabugo de milho pré-tratado com ácido diluído e surfactante para a obtenção de bioetanol
- Laccases produced by Peniophora from marine and terrestrial origin: a comparative study
- An improved method for simple and accurate colorimetric determination of L-asparaginase enzyme activity using Nessler's reagent
- Intensification of bioethanol production by using Tween 80 to enhance dilute acid pretreatment and enzymatic saccharification of corncob
- Increased glycosylated L-asparaginase production through selection of Pichia pastoris platform and oxygen-methanol control in fed-batches
- Glycosylation of Erwinase results in active protein less recognized by antibodies
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
